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Abstract
These data describe the effects of combined aerobic plus resistance training (CT) with regards to risk factors of metabolic
syndrome (MetS), quality of life, functional capacity, and pro- and anti-inflammatory cytokines in women with MetS. In this
context, thirteen women (35.466.2 yr) completed 10 weeks of CT consisting of three weekly sessions of ,60 min aerobic
training (treadmill at 65–70% of reserve heart rate, 30 min) and resistance training (3 sets of 8–12 repetitions maximum for
main muscle groups). Dependent variables were maximum chest press strength; isometric hand-grip strength; 30 s chair
stand test; six minute walk test; body mass; body mass index; body adiposity index; waist circumference; systolic (SBP),
diastolic and mean blood pressure (MBP); blood glucose; HDL-C; triglycerides; interleukins (IL) 6, 10 and 12, osteoprotegerin
(OPG) and serum nitric oxide metabolite (NOx); quality of life (SF-36) and Z-Score of MetS. There was an improvement in
muscle strength on chest press (p= 0.009), isometric hand-grip strength (p= 0.03) and 30 s chair stand (p= 0.007). There was
a decrease in SBP (p = 0.049), MBP (p= 0.041), Z-Score of MetS (p= 0.046), OPG (0.4260.26 to 0.3860.19 ng/mL, p,0.05) and
NOx (13.362.3 mmol/L to 9.162.3 mmol/L; p,0.0005). IL-10 displayed an increase (13.667.5 to 17.2612.3 pg/mL, p,0.05)
after 10 weeks of training. Combined training also increased the perception of physical capacity (p= 0.011). This study
endorses CT as an efficient tool to improve blood pressure, functional capacity, quality of life and reduce blood markers of
inflammation, which has a clinical relevance in the prevention and treatment of MetS.
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Introduction
Metabolic syndrome (MetS) combines several metabolic and
hemodynamic alterations that increase the risks of cardiovascular
diseases and premature death [1]. These risk factors include
central obesity, dyslipidemia, hypertension and elevated fasting
glucose [2]. Moreover, subjects with MetS present with 78%
higher risk of cardiovascular events and death compared with
healthy individuals [1]. According to the National Health and
Nutrition Examination Survey (NHANES) conducted in the
United States between 2003–2006, and the NCEP Adult
Treatment Panel III (ATP III) guidelines, an estimated 34% of
adults aged .20 years met the MetS criteria [3]. It has been
shown that men between 20–50 years of age present higher MetS
prevalence, while these numbers are higher in women after 50
years, which increases the attention of menopause transition
period [4]. Additionally, the residual hypertension risk is increased
by 90% in adult life, classifying this population as a target
candidate for prevention from MetS risk factors [5].
Furthermore, MetS is also associated with chronic low-grade
inflammation, a condition in which inflammatory blood markers
are slightly elevated [6]. Interleukin-6 (IL-6), interleukin-1b (IL-1b)
and tumor necrosis factor-a (TNF-a) cytokines play a central role
on immune responses and inflammatory processes [7]. The
activation of inflammation via Th1 lymphocytes through inter-
leukin-12 (IL-12) has also shown to be involved [8]. Additionally,
such inflammatory cytokines are known to contribute to the
development of atherosclerosis, insulin resistance and hyperten-
sion, which are also criteria for MetS diagnosis [9,10]. Another
blood marker to be considered is osteoprotegerin (OPG), a soluble
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member of the TNF-a receptor superfamily produced by
osteoblasts and vascular endothelial and smooth muscle cells
[11], which may be involved in the regulation of vascular
calcification and mortality [12].
Although nitric oxide (NO) has an important protective role in
cardiovascular function, evidence indicates that higher NO levels
are present in subjects with MetS [13] and diabetes [14]. Both
disorders have been associated with increased atherogenic risk.
Furthermore, elevated NO production may lead to insulin
resistance [15] being another component to those of MetS, which
may be involved in the disease pathophysiology [13].
Furthermore, it has been shown that increased levels of physical
activity and functional capacity may reduce MetS incidence and
seem to be key components for treatment and prevention [16].
Previous investigations have shown that chronic exercise training
reduces the production of pro-inflammatory mediators, enhancing
anti-inflammatory mediator activity, including interleukin-10 (IL-
10). Such functional properties confer to exercise an important
strategy to reduce the low grade inflammatory status of patients
with MetS [17].
Studies with resistance training revealed improvements in lean
mass, strength gain and reduced levels of inflammatory cytokines,
while aerobic training is reported to be effective in improving
maximal oxygen consumption (VO2max), high density lipoprotein
(HDL) levels and reducing the level of triglycerides found in the
plasma [18-20]. Moreover, the combination of aerobic and
resistance training could optimize both cardiovascular and
neuromuscular adaptations [21], which are extremely important
for women with MetS.
According to Stensvold et al. [33], the optimal training regime
to treat MetS and its associated cardiovascular abnormalities
remains uncertain. Furthermore, no previous study focused on the
effects of combined training on OPG, NO and quality of life in
women with MetS.
Thus, this study aims to evaluate the effects of combined aerobic
and resistance training (CT) on cardiometabolic risk factors,
inflammatory blood markers, quality of life and functional capacity
in adult women with MetS. The initial hypothesis is that CT
improves cardiometabolic profile, increases functional capacity
and reduces inflammatory blood markers in women with MetS.
Materials and Methods
Ethics Statement. The protocol for this trial and supporting
CONSORT checklist are available as supporting information; see
Checklist S1 and Protocol S1.
All participants provided and signed a written informed consent
document prior to participation in the study. All procedures were
approved by the Catholic University of Brasilia Research Ethics
Committee for Human Use at November, 29, 2012 (protocol
CEP/UCB, #279/2010) and the study was conducted according
to the principles expressed in the Declaration of Helsinki. The
study was conducted at the laboratory of resistance training of the
Catholic University of Brasilia.
The trial of this study was registered after patient recruitment
began, because only the approval of the Research Ethics
Committee was necessary to conduct the study at the Catholic
University of Brasilia. The authors confirm that all ongoing and
related trial for this intervention is registered.
Participants. Initially, 20 women from the local community
(Vila Telebrasilia, Brazil) volunteered to participate and were
recruited from posters and lectures about the study from January
to April. Each participant received personal explanation after
being informed about the study protocol. Although verbal
encouragement was given to increase compliance during follow-
up (May to July), only 13 completed the study, with two excluded
due to caloric restriction and five excluded from the statistical
analysis because they missed more than 25% of the training
sessions. Individuals completed a thorough physical examination,
including a medical history, resting and exercise electrocardiogram
[22]. Moreover blood pressure assessments, anthropometric and
orthopedic evaluations prior to participation in the experimental
protocols were also performed. As inclusion criteria, the only
participants included were those aged between 18–40 y, classified
with MetS, and those without consistent resistance training for the
past six months before the study period. According to ATP III [2],
MetS is defined as the presence of 3 or more of the following 5
criteria: increased waist circumference ($88 cm), hypertriglycer-
idemia ($150 mg/dL), low HDL (,50 mg/dL), hypertension ($
130/85 mm Hg), and high fasting glucose ($110 mg/dL). A
modified z score was calculated for each variable using individual
subject data using the ATP III criteria. The equations used to
calculate the MetS z score were as follows: {z score = [(50 -
HDL)/11.8] + [(TG 2150)/66.2] + [(fasting blood glucose - 110)/
10.4] + [(waist circumference - 88)/9.2] + [(mean arterial pressure
- 100)/8.7]/100}. Women with physical disabilities, under caloric
restriction, diagnosis of diabetes, cardiovascular diseases, uncon-
trolled hypertension (systolic blood pressure .140 mmHg and
diastolic blood pressure .90 mmHg), musculoskeletal disease,
recent use of medication and smoking or drug/alcohol abuse were
excluded from the trial. A sedentary state was defined by the
International physical activity questionnaire (IPAQ).
Study design. We conducted a 10-week prospective quasi-
experimental design. Participants and those assessing the outcomes
were not blinded to study condition assignment. Subjects were
advised to maintain their normal daily eating habits throughout
the study. Prior to physical evaluation, participants reported to the
laboratory between 08:00–10:00 am following an overnight fast,
for blood sampling from the antecubital vein for subsequent
analysis of the biochemical variables. Volunteers completed two
weeks of familiarization prior to testing (3 sessions/week, with one
exercise for each main muscle group which were the same
exercises used during resistance training), where they were advised
regarding the execution of proper technique. After the familiar-
ization period, one-repetition maximum (1-RM) test and re-test
were performed on the chest press on two nonconsecutive days
with 48–72 h between tests. The CT protocol began three days
after 1-RM testing and was performed on three non-consecutive
days of the week, comprising 30 min of moderate to moderate-
high intensity on a treadmill at 70–80% reserve heart rate and
three sets of 8–12 repetition maximum (RM) of twelve exercises for
whole body, and 1-minute rest intervals between sets and
exercises.
Exercise Training. Training sessions lasted ,60 min in a
facility dedicated to research and under the supervision of exercise
physiologists.
Aerobic training. The aerobic component of the program
consisted of 30 min of moderate to moderate-high intensity on a
treadmill at 70–80% reserve heart rate, with heart rate being
continuously monitored throughout each session.
Resistance training. Subjects completed two weeks of
familiarization prior to the resistance training program. During
the familiarization weeks, individuals were advised regarding
proper resistance training technique and completed 3 sessions/
week, with one exercise of each main muscle group consisting of 3
sets of 10–12 submaximal repetitions. After the familiarization
period subjects initiated the resistance training program consisting
of 3 sessions/week during ten weeks. Resistance training machines
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were from JOHNSON (Landmark Drive, Cottage Grove, USA).
All training sessions were carefully supervised by three experienced
professionals (ratio of supervision 1:2 – 1 professor for 2
participants). Participants were required to complete at least
85% of the exercise sessions. No major complications or cardiac
events occurred during the study period. The resistance training
was divided into A (leg press, knee extensor, leg curl, hip
adduction, hip abduction, standing calf raise and abdominal
crunches), B (chest press, lat pull down, shoulder press, machine
elbow flexion, triceps extension and abdominal crunches) and C
(leg press, knee extensor, leg curl, chest press, lat pull down,
shoulder press and abdominal crunches) regiments. For all listed
exercises, three sets with 8–12 RM were performed, with a one-
minute rest interval between each set and exercise. Training loads
were monitored each session according to the increase in muscle
capacity of the participants. The mean duration to complete one
repetition was 3–4 s (both concentric and eccentric phases of the
movement) and training sessions lasted ,30 min. The number of
repetitions and the loads used for each exercise session were
recorded. The loads were updated when necessary to keep the
number of repetitions within the same range of RM and to provide
a progressive overload. Additionally, correct breathing patterns
were instructed to avoid Valsalva maneuver.
Outcome Measures
Primary Outcomes
Cytokines. Participants reported to the laboratory between
08:00–10:00 am, after an overnight fast, and after blood collection,
samples were centrifuged at room temperature at 2,000 rpm for
15 min. All subjects were encouraged to avoid smoking, alcohol
and caffeine consumption as well as unusual physical activity to
avoid influence on these parameters. The serum was removed and
frozen at 80uC for further analysis. Serum was analyzed for
amyloid A using a DADE Dimension RXL clinical chemistry
analyzer (Dade-Behring, Inc, Newark, DE, USA). The analyzer
was calibrated daily using Liquid-Assayed Multiqual (Bio-Rad,
Hercules, CA, USA), and two levels of quality control with known
concentrations. In addition, serum IL-10, IL-6 and IL-12 were
assessed using commercially available enzyme-linked immunosor-
bent assay (ELISA) kits (BioLegend’s ELISA Max Deluxe, San
Diego, CA, USA) and OPG (R&D System Inc., Minneapolis, MN,
USA). Standard curves were generated using commercially
available microplate reader-compatible statistical software (Micro-
Win 2000, Microtek Laborsysteme GmbH, Overath, Germany).
All samples were determined in duplicate to guarantee the
precision of the results. For all measures the mean intra-assay
coefficient of variation was 2.9–9.5%, the inter-assay coefficient of
variation was 5.9–7.0%, and the sensitivity was 0.0093 pg/mL.
Nitrite Levels. To perform the analysis, the blood was
centrifuged previously. The serum concentration of nitrite was
determined by the Griess reaction. In brief, serum samples were
deproteinized by adding zinc sulfate (15 mg/mL), followed by
centrifugation at 10000 g for 10 min; 100 mL of the supernatant
was applied to a microplate well, and following addition of 100 mL
vanadium (III) chloride (8 mg/mL) to each well, Griess reagents
[50 mL sulfanilamide (2%) and 50 mL N- (1-naphthyl) ethylendia-
mine dihydrochloride (0.1%)] were added. After 30 min incuba-
tion at 37uC, absorbance was read at 540 nm using the ELISA
reader (Sunrise, Tecan, Austria). Concentration of NO2 in serum
samples was determined from the linear standard curve established
by 0–100 mM sodium nitrite.
Secondary Outcomes
Maximal strength testing. After 2 weeks of adaptation to
the exercises and 3–5 days after the last training session, 1-RM test
was performed on chest press exercise on 2 different days
separated by a minimum of 48 h. The protocol consisted of a
light warm-up of 5 min of treadmill walking followed by 8
repetitions at 50% of estimated 1-RM (according to the
participants’ capacity verified in the 2 weeks of adaptation). After
a 1-min rest, subjects performed 3 repetitions at 70% of the
estimated 1-RM. Following 3 minutes of rest, participants
completed 3–5 attempts interspersed with 3-to-5 min rest inter-
vals, with progressively heavier weights (,5%) until the 1-RM was
determined.
Isometric handgrip strength. Isometric handgrip strength
was determined by a manual mechanical dynamometer (Takei,
T.K.K Grip strength dynamometer 0–100 kg, Japan). Volunteers
stood still with both arms extended and the forearm positioned in a
neutral rotation. The handgrip width of the dynamometer was
individually adjusted for each participant, according to hand size
allowing the stem next to the body to be positioned on the second
phalanges: index, medial and ring fingers. Three attempts were
allowed interspersed with 1 min rest intervals. The best measure
was used and relative isometric strength was determined as follows:
Relative strength = Absolute strength (kg)/Body mass (kg) [23].
The 6-minute walk test. The 6-minute walk test (6MWT)
was performed according to the American Thoracic Society
protocol [24]. Functional capacity was determined by the distance
walked in a covered 30-meter walkway.
Functional fitness tests. Two components of the functional
fitness test [25] were selected as a measure of functional
performance. The following test items were conducted as follows:
(1) a 30-s chair stand test (the maximum number of times within
30 s that an individual can rise to a full stand from a seated
position, without pushing off with the arms), and (2) the sit and
reach test evaluated flexibility using the modified chair sit-and-
reach test.
Anthropometrics. Height and weight were measured for the
calculation of the body mass index (BMI). All circumferences were
obtained using non elastic tape, and measurements were obtained
in triplicate and averaged to obtain the circumference score. Neck
circumference was obtained with the subject sitting with the head
in the Frankfort horizontal plane position. Briefly, a measuring
tape was applied around the neck inferior to the laryngeal
prominence and perpendicular to the long axis of the neck, while
the minimal circumference was measured and recorded to the
nearest 0.1 cm [26]. Waist circumference was measured at the
midpoint between the lower rib margin, hip circumference was
measured at the widest portion of the buttocks and the body
adiposity index (BAI) was determined by the following formula:
(BAI = [(hip circumference)/((height)1.5)–18)] [27].
Blood pressure measurement. Systolic (SBP), diastolic
(DBP) were measured with a validated oscillometric device
(Microlife 3AC1-1, Widnau, Switzerland) according to the
recommendations of the International Protocol of the European
Society of Hypertension [28]. The cuff size was adapted to the arm
circumference of each participant according to the manufacturer’s
recommendations, and BP was assessed in triplicate (measure-
ments separated by 5 min) with the mean value used for further
analysis after 10 min of seated rest. All BP measurements were
taken on the left arm. Mean blood pressure (MBP) was calculated
as the sum of DBP and one-third of the pulse pressure. All blood
pressure measures were assessed in triplicate (measurements
separated by 1 min) with the mean value used for analysis.
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Biochemical parameters. Participants reported to the
laboratory between 08:00–10:00 am, after an overnight fast, for
blood withdrawal from the antecubital vein. Plasma triglycerides,
HDL-cholesterol and glucose levels were measured by enzymatic
CHOP-POD, homogeneous HDL-cholesterol and Hexokinase
methods, respectively.
Quality of life. Health-related quality of life was assessed
using the Brazilian version of the Short Form 36 Health Survey
(SF-36) [29]. Quality of life is a multidimensional construction
characterized by four essential components: psychological well-
being; physical functioning; social relations; and functional
competence. The measure assesses eight dimensions. For each
item, patients were required to select the answer closest to their
own experience. The types of answer possible varied from item to
item, from yes or no answers to answers on a scale of 1–6. Each
domain score ranges from 0 to 100, the highest score indicating
better health conditions related to quality of life.
Sample size
The power of the sample size was determined using G*Power
version 3.1.3, based on the differences between pre and post
primary outcomes and the metabolic syndrome z score. Consid-
ering the final sample size of this study and an alpha error of 0.05,
the sample power (12b) was 1.00 for NO, 0.96 for IL-10/NO
ratio and 0.71 for metabolic syndrome z score. Unfortunately, IL-
6 (12b=0,24), IL-12 (12b=0,25), IL-10 (1–b=0,60) and OPG
(1–b=0,57) did not reach the recommended power and interpre-
tation of the data must be careful, specially the IL-6 and the IL-12.
However, the effect sizes of the correlations involving IL-6 and IL-
12 with anthropometric or biochemical variables in this study were
large (|p|.0.5), corresponding to a strong sample power for the
correlations [30].
Statistical analysis
The results are expressed as means 6 standard deviation (SD).
Shapiro-Wilk tests were applied to check for normality distribution
of study variables. In case of nonparametric distribution, a
logarithmic transformation was performed. The anthropometric,
biochemical, NO and physical fitness variables were parametri-
cally distributed, however, the SF-36 scores, cytokines and
osteoprotegerin were nonparametriclly distributed. The pre and
post-intervention variables were compared using paired-samples t-
test (parametric samples) and the Wilcoxon signed-rank test
(nonparametric samples). The Spearman’s correlation was used to
evaluate the correlation between delta (post-pre) cytokines
concentration and anthropometric or biochemical variables and
between physical fitness and SF-36 scores after training program.
The Cohen’s convention (1988) [30] was used for assigning
strength of association between the variables. The level of
significance was p#0.05 and SPSS version 20.0 (Somers, NY,
USA) software was used.
Results
Flow of participants through trial. Initially, 20 women
volunteered to participate. Only 13 completed the study, with two
excluded due to caloric restriction and five excluded from the
Figure 1. Flow-chart of the participants.
doi:10.1371/journal.pone.0110160.g001
Table 1. Anthropometric and hemodynamic characteristics of the subjects (n = 13) before and after the training program (mean6
SD).
Pre Post p-value
Weight, kg 74.867.2 74.267.5 0.352
Body mass index, kg/m2 30.062.5 29.762.0 0.321
Waist circumference, cm 85.864.9 84.965.6 0.237
Hip circumference, cm 105.964.5 105.164.3 0.242
Neck circumference, cm 35.262.1 35.761.6 0.165
Waist to height ratio 0.5460.04 0.5460.03 0.468
Waist to hip ratio 0.8160.04 0.8160.05 0.514
Body adiposity index, % 26.862.6 26.461.9 0.238
Systolic blood pressure, mmHg 119.2614.6 112.769.7 0.049*
Diastolic blood pressure, mmHg 79.5615.6 72.8610.1 0.051
Mean arterial pressure, mmHg 92.8614.6 86.168.8 0.041*
Metabolic syndrome z score 1.2660.17 1.1960.09 0.046*
*Statistically significant (p#0.05).
doi:10.1371/journal.pone.0110160.t001
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statistical analysis because they missed more than 25% of the
training sessions (figure 1).
Subject Characteristics. On average, volunteers attended
2063 training sessions during the 10-week training program.
Table 1 presents the anthropometric and hemodynamic charac-
teristics of the subjects before and after the training program.
There were no statistically significant differences after 10-weeks of
the training program with respect to anthropometric variables (p$
0.05).
Metabolic Risk Factors. Analyses of HDL (44.569.5 mg/
dL pre to 46.468.8 mg/dL post training, p=0.392), glucose
(88.668.4 mg/dL pre to 88.364.6 mg/dL post training,
p=0.882) and triglyceride (118.0656.5 mg/dL pre to
118.5661.8 mg/dL post training, p=0.910) concentrations did
not reveal any significant changes. However, there was a
significant decrease in systolic (p = 0.049), mean arterial pressure
(p = 0.041) and metabolic syndrome z score (p = 0.046).
Inflammation blood markers. After the 10-week training
program, the NO plasma concentration had a significant decrease
(13.362.3 mmol/L to 9.162.3 mmol/L; p,0.0005; figure 2).
Interestingly, NO was reduced after the training program for all
volunteers. The minimum decrease was approximately 15% and
the maximum was 60% (31.8612.1%). There was a significant
increase in IL-10 concentration (p=0.043) and a significant
decrease in OPG concentration (p=0.034) after the training
program. There were no statistically significant differences (p$
0.05) pertaining to IL-6 or IL-12 concentrations after the training
program (table 2). The ratio IL-10/NO also displayed a significant
increase (p=0.008) as a result of the training program. The
Spearman’s correlations between cytokine concentration and
anthropometric or biochemical variables are presented in table 3.
According to Cohen (1988), the strength of association for all
significant correlations (p#0.05) presented in this study were large
correlations.
Functional fitness tests. Table 4 presents the physical
fitness tests performed before and after the training program.
There was a significant increase for the sitting-rising test
(p=0.007), and chest and handgrip strength (p#0.05) after
completion of the training program. There were no statistically
significant increases in flexibility (p=0.402) or the 6-min walking
tests (p=0.606).
Quality of life. The SF-36 scores were shown in table 5.
Among the eight domains of the SF-36, physical function scale was
the only one that had a significant increase (p=0.011) after the
training program. There were positive correlations of post 6-min
walking test score with post SF-36 scores of physical function
(r=0.586, p=0.035), role physical (r=0.582, p=0.037), general
health (r=0.631, p=0.021) and role emotional (r=0.676,
p=0.011). The post flexibility score after the training program




The main findings of the present study provide evidence that 10
weeks of CT decrease chronic inflammation, blood pressure, Z-
Score of MetS, and improve muscle strength, quality of life and
functional capacity in adult women with MetS, confirming the
initial hypothesis. Moreover, although there was no weight loss,
women with MetS decreased blood markers of low-grade
inflammation associated with overweight and obesity.
CT is widely used due to the unique advantages of aerobic and
resistance training. Aerobic training has been shown to improve
cardiorespiratory fitness, promoting energy expenditure and fat
utilization, while resistance training induces gains in muscle size,
strength, endurance, and power. Furthermore, CT has been
reported not only to reduce health risks and symptoms associated
with physical inactivity, but improves performance of daily living
activities [21,31].
MetS is associated with chronic low-grade inflammation, a
condition in which inflammatory markers in the circulation are
slightly elevated [32]. In our study, there was a significant decrease
in blood markers of inflammation (OPG and NO) and an increase
of anti-inflammatory cytokines (IL-10) following ten weeks of CT.
The change in IL-6 and IL-12 could not be shown, however,
because the lack of sample power for these variables, the result
warrants confirmation. Meanwhile, it was shown a large correla-
tion between the change in body adiposity index and IL-6 or IL-12
Figure 2. Nitric oxide (NO) concentration before (pre) and after
(post) the training program (mean ± SD). *Statistically different
compared with pre-values (p#0.05).
doi:10.1371/journal.pone.0110160.g002
Table 2. Evaluation of Interleukin-10 (IL-10), osteoprotegerin (OPG), interleukin-6 (IL-6) and interleukin-12 (IL-12) concentrations
before and after the training program (mean 6 SD).
Pre Post p-value
IL-10, pg/mL 14.9667.48 19.38612.30 0.043*
OPG, pg/mL 0.4960.26 0.4360.19 0.034*
IL-6, pg/mL 0.6361.95 0.1360.33 0.276
IL-12, mg/dL 1.0461.49 0.6660.89 0.237
IL-10/NO 1.2160.53 2.3561.36 0.008*
*Statistically significant (p#0.05).
doi:10.1371/journal.pone.0110160.t002
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concentrations after CT. Recently, Stensvold et al (2012) [33]
reported that after 12 weeks of aerobic interval training the levels
of TNF-a were lower as compared to resistance trained and
control groups in subjects with MetS. However, different from the
present study, total body fat was reduced with aerobic interval
training (from 33.967.3% to 32.267.9%) and resistance training
(from 31.263.9% to 29.763.4%). Similarly, Ho et al (2013) [34]
found that 12 weeks of moderate-intensity aerobic (60% heart rate
reserve), resistance training (four sets of 8–12 repetitions at 10-RM
level of 5 whole body exercises), and CT (15 min of aerobic
exercise and 2 sets of 8–12 repetitions of 5 whole body exercises)
decreased TNF-a in overweight and obese individuals compared
to a control group.
Growing evidence suggests that NO plays an important role in
the development of MetS [35,13]. Previous studies reported that
increased plasma NO concentration in hypertensive coronary
artery disease patients might represent a compensatory response to
increased superoxide anion concentration [36]. Moreover, in-
creased shear stress with hypertension might stimulate NO
production. Zahedi et al (2008) [13] also have found similar
results and suggested that nonspecific tissue damage in MetS and
diabetes might increase the activity of inducible nitric oxide
synthase (iNOS), and therefore results in the accumulation of NO.
In our study, there was a significant decrease in NO levels
following 10 weeks of CT. The decrease in NO and OPG in
response to CT reveal important protective effects against the
deleterious effects of low-grade inflammation in women with
MetS.
The increase in the anti-inflammatory response following CT,
represented by the increased levels of IL-10 may have contributed
to the decrease of blood markers of inflammation (OPG and NO),
as shown in previous studies [37,38].
Nevertheless, data reveal that despite improvements in the
cardiovascular risk factors of MetS (blood pressure and inflam-
mation) and the increase in functional capacity, no modifications
with respect to blood glucose, HDL-C and triglycerides were
observed. Similarly, meta-analytic data revealed that isolated
exercise programs without caloric restriction induced limited
improvements in such parameters. Shaw et al (2006) [39]
evaluated 43 studies including 3476 participants and found that
exercise without caloric restriction control is associated with a
lower decrease of body mass, blood pressure and blood glucose as
compared with exercise associated with dietary restriction. Orozco
et al (2008) [40] compared the effects of isolated diet and diet plus
CT. Results revealed that diabetes risk was lower in the combined
group. Additionally, individuals submitted to combined exercise
training and diet presented a decrease in blood pressure and
obesity anthropometric indexes, which was not observed for the
group participating in exercise alone.
Regarding the quality of life, it has been reported that subjects
with MetS have reduced perception of quality of life [40].
Recently, Okosun et al (2013) [41] found that MetS is associated
with poor physical health (1.65; 95% CI= 1.0922.50), mental
health (1.67; 95% CI= 1.0922.83) and overall health (1.44; 95%
CI= 0.8022.59) in Mexican-Americans. In the present study, it
was observed that CT improved the perception of physical
function in adult women with MetS. Our findings were similar to
Table 3. Spearman’s correlations between cytokines concentration and anthropometric or biochemical variables.
IL-10 OPG IL-6 IL-12
Delta (post-pre) correlations
Neck circumference NS NS 0.616* NS
Body adiposity index NS NS 0.637* 0.572*
HDL NS NS 0.649* 0.723*
NO NS NS NS NS
IL-10, interleukin-10; OPG, osteoprotegerin; IL-6, interleukin-6; IL-12, interleukin-12; HDL, high-density lipoprotein; NO, nitric oxide; NS, non-significant; *Statistically
significant (p#0.05).
doi:10.1371/journal.pone.0110160.t003
Table 4. Physical fitness tests performed before and after the training program (mean 6 SD).
Pre Post p-value
Sitting-rising, rep 20.364.0 24.564.6 0.007*
Flexibility, cm 28.669.3 29.368.7 0.402
6-min walking, m 587.4642.9 581.3648.2 0.606
Chest press 1RM, kg 55.866.8 59.869.4 0.009*
Chest press relative strength 0.7560.09 0.8160.10 0.002*
Right handgrip, kg 33.767.7 35.067.7 0.030*
Right handgrip relative strength 0.4560.09 0.4760.08 0.008*
Left handgrip, kg 31.167.2 32.566.1 0.024*
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previous trials in subjects with type 2 diabetes [42] and obesity
[43]. Imayama et al (2011) [44] examined the individual and
combined effects of dietary weight loss and/or exercise interven-
tions (moderate to vigorous aerobic exercise/225 min per week)
on health-related quality of life (HRQOL) in overweight/obese
postmenopausal women. This same report showed that a
combined diet and exercise intervention had positive effects on
HRQOL and psychological health, which may be greater than
that of exercise or diet alone. Thus, it is likely that the CT program
utilized in the present study would provide additional improve-
ments in quality of life parameters if combined with a dietary
restriction intervention.
The present study has some limitations that should be
considered, such as the limited time of the intervention (only ten
weeks), the reduced sample power for cytokines, and the lack of
more accurate measures to evaluate body composition (body fat
and lean body mass), which may have influenced the results.
Another limitation was the lack of a control group, although it has
been speculated that a control group is not always necessary,
particularly considering that the health of the subjects could be
compromised as a result of not participating in CT. Additionally,
results from a control group would probably reveal no positive
effect on anthropometric, biochemical and cardiovascular risk
factors of MetS, as has been reported in a previous study [44].
Finally, the non-significant variation with the biochemical data,
such as glucose, triglycerides and HDL-C can be, at least in part
attributed to the lack of dietetic control, as well as the limited
sample size. It is possible that an interdisciplinary approach would
induce more positive results in biochemical and anthropometric
variables, as previously found in other studies. However,
‘‘significant’’ results based upon this exploratory research should
clearly be labeled as exploratory results. To confirm these results
the corresponding hypotheses have to be tested in further
confirmatory studies.
In summary, ten weeks of CT reduced blood markers of
inflammation such as NO, IL-10 and OPG, blood pressure and
metabolic syndrome Z scores in women with MetS. Moreover, the
improvement of the quality of life (physical function domain) and
functional capacity (leg, chest and handgrip strength) reinforce the
clinical relevance of CT for women with MetS. Thus, the results of
this study provide further evidence for the recommendation of
regular CT to decrease cardiovascular risk factors of MetS.
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